Private Placement

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

Daxor reports a transformative year with 45% revenue growth, a new FDA-cleared portable analyzer, and a full pivot to a high-growth medtech company.

Axxess's upcoming conference tackles AI's role in home health, unveils a new leadership certification, and honors an industry titan. Here's what it means.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

Greenwich LifeSciences' Phase III trial for its GLSI-100 immunotherapy is enrolling patients faster than ever, with early data echoing past success.

A massive US$175M investment in EverWind is set to transform Nova Scotia into a clean energy powerhouse, with a groundbreaking Indigenous partnership at its core.

With new CEO Ahmad Moradi, AI Era Corp. is pivoting from IP firm to AI content creator. Can its ambitious tech and NFT plans disrupt Hollywood?

Great Hill Partners appoints AI head Leland Lockhart, signaling a critical trend where specialized tech leadership becomes the new frontier for value creation.

Surging investor demand boosts a financing deal to C$35M, positioning American Tungsten to restart a historic Idaho mine and tackle critical mineral scarcity.

The industry's largest independent support provider modernizes its brand to reflect a strategic shift into a full-lifecycle ecosystem for aircraft owners.

As SAB Biotherapeutics prepares for key investor talks, a closer look reveals its novel T1D therapy and the unique bovine tech aiming to change treatment.

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

A new study reveals a massive shift in perception, with pro gaming now a top career choice for Gen Z, backed by a multi-billion dollar industry.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

The New York-based bank will now originate FHA-insured loans nationwide, positioning it to capitalize on the growing demand for senior care facilities.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

A key clinical milestone for its MS drug azer-cel nets Precision BioSciences $7.5M, extending its financial runway and boosting hope for patients.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.